Cargando…
Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
Mitochondrial dysfunction in the spinal cord is a hallmark of amyotrophic lateral sclerosis (ALS), but the neurometabolic alterations during early stages of the disease remain unknown. Here, we investigated the bioenergetic and proteomic changes in ALS mouse motor neurons and patients’ skin fibrobla...
Autores principales: | Szelechowski, M., Amoedo, N., Obre, E., Léger, C., Allard, L., Bonneu, M., Claverol, S., Lacombe, D., Oliet, S., Chevallier, S., Le Masson, G., Rossignol, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834494/ https://www.ncbi.nlm.nih.gov/pubmed/29500423 http://dx.doi.org/10.1038/s41598-018-22318-5 |
Ejemplares similares
-
High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy
por: Imasawa, Toshiyuki, et al.
Publicado: (2017) -
RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2018) -
Proteomic Study of Low-Birth-Weight Nephropathy in Rats
por: Imasawa, Toshiyuki, et al.
Publicado: (2021) -
Current view and perspectives in amyotrophic lateral sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2017) -
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019)